Skip to content

Effect of CI on Prognosis in the Elderly Patients With ACS

Effect of Cognitive Impairment (CI) on Prognosis in the Elderly Patients With Acute Coronary Syndrome (ACS)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04278911
Acronym
CIACS
Enrollment
500
Registered
2020-02-20
Start date
2020-01-01
Completion date
2022-06-30
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Cognitive Impairment, Elderly

Brief summary

This study aims to investigate the incidence and characteristics of cognitive Impairment(CI) in the elderly patients with acute coronary syndrome (ACS), and to determine whether CI are predictive of the prognosis of major adverse cardiovascular events (MACE) and mortality.

Interventions

DIAGNOSTIC_TESTMMSE and MoCA

This is an observational study. All the patients evaluate with MMSE (Mini-mental State Examination) and MoCA (Montreal Cognitive Assessment), and investigate the incidence and characteristics of cognitive and MACE

Sponsors

Beijing Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥65yr * Confirmed ACS diagnosis (include unstable angina, ST-segment elevation myocardial infarction and Non ST-segment elevation myocardial infarction) * fulfilled MMSE or MoCA * patients agreed and provided informed consent

Exclusion criteria

* Type 2 myocardial infarction and Acute nonischemic myocardial injury * past history of malignant tumors * Past history of stroke or dementia * Hepatic insufficiency (ALT\>8ULN or ALT\>3ULN and TBIL\>2ULN) * Renal insufficiency (GFR\<15 ml/min/1.73m2)

Design outcomes

Primary

MeasureTime frameDescription
MACE (major adverse cardiovascular events)12 monthsMyocardial infarction, revascularization, stroke, cardiac death, all cause of death

Secondary

MeasureTime frameDescription
Cognitive level decline12 monthsEvaluate with MMSE (Mini-mental State Examination)

Countries

China

Contacts

Primary ContactHongwei Li, Prof.
lhw19656@sina.com0086 10 63139780

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026